HRP920903B1 - Indenoindole compounds and a process for preparing the same - Google Patents

Indenoindole compounds and a process for preparing the same

Info

Publication number
HRP920903B1
HRP920903B1 HRP-1223/90A HRP920903A HRP920903B1 HR P920903 B1 HRP920903 B1 HR P920903B1 HR P920903 A HRP920903 A HR P920903A HR P920903 B1 HRP920903 B1 HR P920903B1
Authority
HR
Croatia
Prior art keywords
lower alkyl
hydrogen
group
cor
alkyl group
Prior art date
Application number
HRP-1223/90A
Other languages
English (en)
Inventor
Howard G Shertzer
Original Assignee
Howard G. Shertzer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howard G. Shertzer filed Critical Howard G. Shertzer
Publication of HRP920903A2 publication Critical patent/HRP920903A2/hr
Publication of HRP920903B1 publication Critical patent/HRP920903B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HRP-1223/90A 1989-06-22 1992-10-02 Indenoindole compounds and a process for preparing the same HRP920903B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8902274A SE8902274D0 (sv) 1989-06-22 1989-06-22 Indenoidole compounds ii
YU122390A YU122390A (sh) 1989-06-22 1990-06-22 Indenoindolova jedinjenja ii

Publications (2)

Publication Number Publication Date
HRP920903A2 HRP920903A2 (hr) 1994-04-30
HRP920903B1 true HRP920903B1 (en) 1998-06-30

Family

ID=20376370

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-1223/90A HRP920903B1 (en) 1989-06-22 1992-10-02 Indenoindole compounds and a process for preparing the same

Country Status (34)

Country Link
EP (1) EP0409410B1 (zh)
JP (1) JP3064411B2 (zh)
KR (1) KR920702679A (zh)
CN (1) CN1033029C (zh)
AT (1) ATE135688T1 (zh)
BG (1) BG60317B2 (zh)
CA (1) CA2060897A1 (zh)
DD (1) DD297960A5 (zh)
DE (1) DE69025998T2 (zh)
DK (1) DK0409410T3 (zh)
DZ (1) DZ1428A1 (zh)
ES (1) ES2084660T3 (zh)
FI (1) FI100800B (zh)
GR (1) GR3019779T3 (zh)
HR (1) HRP920903B1 (zh)
HU (1) HUT59097A (zh)
IE (1) IE74682B1 (zh)
IL (1) IL94830A (zh)
IS (1) IS3590A7 (zh)
LT (1) LT3675B (zh)
LV (1) LV10253B (zh)
MX (1) MX21244A (zh)
MY (1) MY107311A (zh)
NO (1) NO177932C (zh)
NZ (1) NZ234175A (zh)
PL (1) PL167761B1 (zh)
PT (1) PT94468B (zh)
RO (1) RO111573B1 (zh)
RU (1) RU2104270C1 (zh)
SE (1) SE8902274D0 (zh)
SI (1) SI9011223B (zh)
WO (1) WO1990015799A1 (zh)
YU (1) YU122390A (zh)
ZA (1) ZA904827B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8713291A (en) * 1990-10-16 1992-05-20 University Of Bath Indenoindole compounds
JPH0656669A (ja) * 1992-06-11 1994-03-01 Asahi Breweries Ltd 活性酸素消去作用を持つプテリン誘導体製剤
SE9302431D0 (sv) * 1993-07-16 1993-07-16 Ab Astra Use of indenoindole compounds
AU675141B2 (en) * 1993-07-20 1997-01-23 Adir Et Compagnie (Thia)cycloalkyl(b)indoles, process for preparing them and pharmaceutical compositions containing them
BR9915900A (pt) * 1998-12-04 2001-08-21 American Home Prod Composto, composição farmacêutica, e, processo para tratar ou inibir distúrbios associados com contração da musculatura lisa.
US6288099B1 (en) 1998-12-04 2001-09-11 American Home Products Corporation Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
FR2826009B1 (fr) * 2001-06-13 2003-08-15 Servier Lab Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2008000462A (es) 2005-07-14 2008-03-10 Irm Llc Compuestos heterotetraciclicos como mimeticos de tpo.
DE102006047231B4 (de) * 2006-10-04 2009-02-12 Hemmerling, Hans-Jörg, Dr. Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika
MX363405B (es) * 2011-06-16 2019-03-22 Katholieke Univ Leuven K U Leuven R&D Derivados de indanona, sales farmaceuticamente aceptables o isomeros opticos de los mismos, metodo de preparacion de los mismos, y composiciones farmaceuticas que contienen los mismos como ingrediente activo para prevención o tratamiento de enfermedades virales.
WO2014092514A1 (ko) 2012-12-14 2014-06-19 한국화학연구원 신규한 화합물, 이의 약학적으로 허용가능한 염 또는 이의 광학 이성질체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물

Also Published As

Publication number Publication date
LT3675B (en) 1996-01-25
DK0409410T3 (da) 1996-04-29
CN1051554A (zh) 1991-05-22
PT94468A (pt) 1991-02-08
PT94468B (pt) 1997-12-31
FI915999A0 (fi) 1991-12-19
IS3590A7 (is) 1990-12-23
YU122390A (sh) 1992-09-07
AU644084B2 (en) 1993-12-02
EP0409410B1 (en) 1996-03-20
NO177932C (no) 1995-12-20
DE69025998T2 (de) 1996-08-08
IE902247A1 (en) 1991-01-16
NO915049L (no) 1992-02-21
DD297960A5 (de) 1992-01-30
ATE135688T1 (de) 1996-04-15
DZ1428A1 (fr) 2004-09-13
KR920702679A (ko) 1992-10-06
NZ234175A (en) 1992-12-23
FI100800B (fi) 1998-02-27
JP3064411B2 (ja) 2000-07-12
LTIP912A (en) 1995-03-27
ZA904827B (en) 1991-04-24
WO1990015799A1 (en) 1990-12-27
IL94830A (en) 1996-07-23
HRP920903A2 (hr) 1994-04-30
PL285752A1 (en) 1991-03-11
SI9011223B (sl) 1998-08-31
HUT59097A (en) 1992-04-28
RU2104270C1 (ru) 1998-02-10
GR3019779T3 (en) 1996-07-31
CA2060897A1 (en) 1990-12-23
MX21244A (es) 1994-03-31
HU904825D0 (en) 1992-03-30
SE8902274D0 (sv) 1989-06-22
AU5836990A (en) 1991-01-08
IE74682B1 (en) 1997-07-30
NO177932B (no) 1995-09-11
LV10253B (en) 1995-04-20
DE69025998D1 (de) 1996-04-25
SI9011223A (en) 1997-10-31
MY107311A (en) 1995-11-30
PL167761B1 (pl) 1995-10-31
EP0409410A1 (en) 1991-01-23
LV10253A (lv) 1994-10-20
ES2084660T3 (es) 1996-05-16
RO111573B1 (ro) 1996-11-29
CN1033029C (zh) 1996-10-16
IL94830A0 (en) 1991-04-15
BG60317B2 (bg) 1994-07-25
NO915049D0 (no) 1991-12-20
IE902247L (en) 1990-12-22
JPH04505923A (ja) 1992-10-15

Similar Documents

Publication Publication Date Title
EP0163599A3 (en) Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents
GR3004139T3 (zh)
HRP920903B1 (en) Indenoindole compounds and a process for preparing the same
ZA853719B (en) New beta-carboline-3-oxadiazolyl derivatives,method of preparing the same and their use
EP0161575A3 (en) B-carboline-3-carboxylic acid derivatives, method of preparing the same and their use
SE8902273D0 (sv) Indenoindole compounds i
YU59688A (en) Process for obtaining benzazepin sulphanamide
GR3003126T3 (en) Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments
JO1676B1 (en) Extra compounds indinol II
EP0470832A3 (en) Biphenyl 5, 5'-bis-alkanoic acid derivatives, their production and use thereof
DE3362523D1 (en) Optically active imidazolylpropanol compounds, and their production and use
GB2021587A (en) Benzoquinolizines

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 19980622

Year of fee payment: 9

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 19990623